Adults with focal onset seizures experienced significant reductions in their seizure frequency with azetukalner, according to ...
In a phase 3 trial, the agent reduces seizure frequency by up to 53% in treatment-resistant focal epilepsy, with rapid onset ...
MedPage Today on MSN
Novel agent reduces seizures in treatment-resistant epilepsy
Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study ...
The study sought to evaluate the efficacy, safety, and tolerability of azetukalner, administered as an oral, adjunctive, once ...
Late-onset epilepsy (LOE) may represent a distinctive neurodegenerative-linked epilepsy subtype, with new data showing that individuals who develop epilepsy after midlife have substantially greater ...
Patients can spend anywhere from several days to several weeks in an epilepsy monitoring unit with electrodes protruding from holes drilled in their skulls. This is intracranial EEG, and it is now ...
Hypertensive disorders of pregnancy were tied to higher risks of new-onset neurologic conditions later in life. Women with eclampsia had a five-times higher risk of developing epilepsy. Migraine risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results